People with rheumatoid arthritis with varying physical abilities have varying abilities to use inhalers without help. A person-centred approach is required to assess which inhaler device is appropriate for each individual patient.
- Respiratory disease is a common co-morbidity with rheumatoid arthritis (RA).
- People with rheumatoid arthritis are less likely to be able to operate inhalers.
- A person-centred approach is required when prescribing inhaler devices.
Arthritis often affects the hands making complex or finely controlled actions difficult and painful.
Arthritis patients struggle to use the commonly available inhalers
The team recruited 34 patients with rheumatoid arthritis and compared how well they could use four types of commonly prescribed inhalers to a healthy control group.
They discovered that only 15 percent of the arthritis patients could complete all the steps to use one type of inhaler, called a HandiHaler, whereas 94 percent of the control group were able to. The HandiHaler requires seven steps to operate it properly, including removing a capsule of powered medicine from a foil blister pack, inserting it into the inhaler and piercing it for inhalation.
In contrast 85 percent of the arthritis patients and 100 percent of the control group could correctly use an inhaler called a Turbohaler, which has three steps; unscrewing a cap, twisting a dial and replacing the cap.
The need for user-friendly inhalers
Dr Matthew Jones, from the Department of Pharmacy & Pharmacology, said: "These results show how important it is that health professionals make sure people can use any inhaler they prescribe. If someone gets home from a pharmacy with a new inhaler and finds they can't use it, their lung disease will not be properly treated and the NHS loses money, as some inhalers cost more than 50 British pounds each.
"Pharmacists, doctors and nurses need to make these easy checks not only help patients achieve better outcomes but also reduce demand on the NHS, not to mention taking away the stress and irritation of a complex and difficult process for the patient. It's a no-brainer."
In the year to November 2017, 4.5 million HandiHalers were dispensed in the NHS in England alone to approximately 375,000 people at a cost of 135 million British pounds.
Undergraduate pharmacy student Yasmin Shirmanesh, who conducted the study with Dr Jones, said: "Some of these inhalers are prescribed by the millions around the UK, so I was shocked to see the difference in how difficult patients find some types to use. If an inhaler can't be used properly it's no good for the patient, and a waste of money for the NHS.
"No-one wants to see patients struggle needlessly to take the medicines they need to manage serious conditions, so I hope that our study will lead to change in how inhalers are prescribed."
References:
- Yasmin Kafaei Shirmanesh, Matthew D. Jones. Physical Ability of People with Rheumatoid Arthritis and Age-sex Matched Controls To Use Four Commonly Prescribed Inhaler Devices, Respiratory Medicine DOI: https://doi.org/10.1016/j.rmed.2017.12.014
Source-Eurekalert